Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

24 participants · First posted Nov 6, 2000

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

5 participants · First posted Jun 30, 2014

HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

70 participants · First posted Apr 15, 2022

Selumetinib(Koselugo)

C₁₇H₁₅BrClFN₄O₃

Neurofibromin

Drug Candidate for neurofibromatosis type 1-cutaneous neurofibroma (Healx)

Neurofibromatosis Type 1 with Plexiform Neurofibromas: Diagnosis, Epidemiology and Clinical Manifestations

FDA Grants Priority Review to Mirdametinib for NF1-Associated Plexiform Neurofibromas

Health Canada Approves Koselugo for Adult Neurofibromatosis Type 1 Patients with Plexiform Neurofibromas